Clinical Trial Update: Homocysteine Study (HOST) [Phase 3]

View source ↗

Summary

Phase 3 trial update for the Homocysteine Study (HOST) completed; conditions include end-stage renal disease and renal failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Renal Failure

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: End Stage Renal Disease, Renal Failure | Phase 3 | Status: COMPLETED